Today: 29 June 2026
Bloom Energy stock pops again after hours — why BE is moving and what traders watch next
16 January 2026
1 min read

Bloom Energy stock pops again after hours — why BE is moving and what traders watch next

New York, Jan 15, 2026, 19:46 ET — After-hours

  • After the bell, Bloom Energy’s shares climbed 4.3%, reaching as high as $144.41 during the session.
  • This move builds on a January streak linked to a major fuel-cell supply agreement revealed by American Electric Power.
  • Attention now shifts to late-February earnings, alongside the question of whether the Wyoming project meets critical conditions.

Bloom Energy Corp shares climbed 4.3% to $139.17 in after-hours trading Thursday, having briefly touched $144.41 earlier in the session.

The latest surge keeps the fuel-cell maker locked into a market narrative drawing in utilities, data-center developers, and an expanding group of momentum traders.

The pitch is straightforward: data centers demand reliable power delivered quickly, and a significant portion of that demand seeks sources outside the traditional grid queue.

American Electric Power revealed last week that its unit will purchase a large portion of an option for solid oxide fuel cells, in a deal valued at roughly $2.65 billion. This move is linked to a planned fuel-cell generation plant near Cheyenne, Wyoming. The utility also announced a 20-year offtake agreement covering the plant’s entire output, though the contract depends on certain conditions expected to be met by the second quarter of 2026.

Solid oxide fuel cells generate electricity via an electrochemical reaction instead of combustion, making them appealing for on-site power applications where noise, emissions, and space constraints are critical.

Evercore ISI analyst Nicholas Amicucci described the AEP deal as a “meaningful positive,” Barron’s reported, highlighting improved clarity on volumes exceeding the minimum commitment. Barron’s

Traders now face the challenge of seeing if the stock can maintain its gains as focus moves beyond headlines to execution—timing of projects, production capacity, and the speed at which orders convert into booked revenue.

But there’s a familiar hitch: the offtake deal depends on conditions. Large infrastructure projects often face delays in permits, supply chains, or financing—any of these can push back expected deliveries and cash flow.

Bloom hasn’t set a date for its next quarterly report yet, though market calendars point to a release around Feb. 26, after the market closes.

Investors are gearing up for that report, which could be the next major hurdle. They’ll focus on backlog details linked to big data-center orders, updates on the Wyoming buildout, and whether margins and cash flow can keep up with the stock’s rally.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Nasdaq Jumps, Dow Hits 52,000 as Tech Names Rebound
    June 29, 2026, 4:52 PM EDT. U.S. stocks ended higher Monday, with Nasdaq up 1.84% as big tech names recovered. The Dow Jones Industrial Average finished above 52,000 for the first time, closing at 52,234.45, a gain of 0.69%. The S&P 500 advanced 1.07%. Alphabet Inc. surged 4.6% after replacing Verizon in the Dow. Market breadth was mixed. NYSE advancers outpaced decliners 1.31-to-1, but the S&P 500 saw no new 52-week highs. Citi flagged a rare momentum dip in the Magnificent Seven, which dropped 6% equal-weighted last week. Traders are watching June payrolls heading into the holiday. The market is keeping a cautious stance before earnings.
Bitcoin price nears $97,000 as ETF inflows rebound and Senate crypto bill stalls
Previous Story

Bitcoin price nears $97,000 as ETF inflows rebound and Senate crypto bill stalls

Merck stock slips as FDA fast-track questions build and earnings near
Next Story

Merck stock slips as FDA fast-track questions build and earnings near

Go toTop